论文部分内容阅读
目的:对盐酸莫西沙星联合康妇消炎栓治疗盆腔炎效果进行观察研究。方法:随机选取我院接收诊治的100例盆腔炎患者,依据所接受不同治疗手段划分成研究组和对照组,各50例,对照组接受单纯盐酸莫西沙星治疗,研究组接受盐酸莫西沙星联合康妇消炎栓治疗,就两个组别治疗效果进行观察对比。结果:研究组总有效率98.0%,对照组总有效率76.0%,研究组总有效率相较于对照组显著更优(P<0.05);两组患者经治疗后,CRP、TNF-α均有所改善(P<0.05);且研究组改善情况要优于对照组(P<0.05)。结论:盐酸莫西沙星联合康妇消炎栓治疗盆腔炎效果满意,具备临床推广价值。
Objective: To observe the effect of moxifloxacin combined with Kangfu anti-inflammatory suppository on pelvic inflammatory disease. Methods: A total of 100 patients with pelvic inflammatory disease admitted to our hospital were randomly divided into study group (50 cases) and control group (50 cases). The control group received moxifloxacin hydrochloride alone. The study group received moxifloxacin hydrochloride Combined Kang Fu anti-inflammatory suppository treatment, the two groups were observed and compared the effect of treatment. Results: The total effective rate was 98.0% in the study group and 76.0% in the control group. The total effective rate in the study group was significantly better than that in the control group (P <0.05). After treatment, CRP and TNF-α (P <0.05). And the improvement of the study group was better than that of the control group (P <0.05). Conclusion: Moxifloxacin combined with Kangfu anti-inflammatory suppository treatment of pelvic inflammatory disease with satisfactory results, with clinical value.